LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 10 of 15: Cell count and normalized growth rate inhibition values within biological replicate 3. - Dataset - HMS LINCS Database

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 10 of 15: Cell count and normalized growth rate inhibition values within biological replicate 3. - Dataset (ID:20247)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells

|<
<<
Previous
Page 300 of 535
Next
>>
>
7476 to 7500 of 13356 records
per page:

Cell	Small Molecule	Small Mol Concentration	Small Mol Conc Unit	LJP Library Plate	Replicate	Assay Well	Timepoint	Timepoint Unit	Total Cell Count Before Treatment	Total Cell Count After Treatment	Total Control Cell Count	Relative Cell Count	Normalized Growth Rate Inhibition Value
BT-20	WYE-125132	0.12	uM	LJP6	3	L11	72	hr	1097	1363	3696	0.3687	0.1318
BT-20	WYE-125132	0.37	uM	LJP6	1	L10	72	hr	1097	1287	3610	0.3565	0.0973
BT-20	WYE-125132	0.37	uM	LJP6	2	L10	72	hr	1097	1303	3713	0.3509	0.1026
BT-20	WYE-125132	0.37	uM	LJP6	3	L10	72	hr	1097	1369	3696	0.3704	0.1346
BT-20	WYE-125132	1.11	uM	LJP6	1	L09	72	hr	1097	1083	3610	0.3000	-0.0076
BT-20	WYE-125132	1.11	uM	LJP6	2	L09	72	hr	1097	1285	3713	0.3460	0.0940
BT-20	WYE-125132	1.11	uM	LJP6	3	L09	72	hr	1097	1390	3696	0.3760	0.1445
BT-20	WYE-125132	3.33	uM	LJP6	1	L08	72	hr	1097	1170	3610	0.3241	0.0381
BT-20	WYE-125132	3.33	uM	LJP6	2	L08	72	hr	1097	1219	3713	0.3282	0.0616
BT-20	WYE-125132	3.33	uM	LJP6	3	L08	72	hr	1097	1111	3696	0.3006	0.0071
BT-20	WYE-125132	10	uM	LJP6	1	L07	72	hr	1097	957	3610	0.2651	-0.0765
BT-20	WYE-125132	10	uM	LJP6	2	L07	72	hr	1097	1090	3713	0.2935	-0.0038
BT-20	WYE-125132	10	uM	LJP6	3	L07	72	hr	1097	982	3696	0.2657	-0.0614
BT-20	Barasertib	0.04	uM	LJP5	1	D12	72	hr	1097	2556	3735	0.6843	0.6136
BT-20	Barasertib	0.04	uM	LJP5	2	D12	72	hr	1097	3022	3877	0.7793	0.7441
BT-20	Barasertib	0.04	uM	LJP5	3	D12	72	hr	1097	3176	3925	0.8091	0.7824
BT-20	Barasertib	0.12	uM	LJP5	1	D11	72	hr	1097	2112	3735	0.5654	0.4485
BT-20	Barasertib	0.12	uM	LJP5	2	D11	72	hr	1097	1765	3877	0.4552	0.2982
BT-20	Barasertib	0.12	uM	LJP5	3	D11	72	hr	1097	2637	3925	0.6718	0.6109
BT-20	Barasertib	0.37	uM	LJP5	1	D10	72	hr	1097	1896	3735	0.5076	0.3627
BT-20	Barasertib	0.37	uM	LJP5	2	D10	72	hr	1097	1972	3877	0.5085	0.3797
BT-20	Barasertib	0.37	uM	LJP5	3	D10	72	hr	1097	2256	3925	0.5747	0.4799
BT-20	Barasertib	1.11	uM	LJP5	1	D09	72	hr	1097	1638	3735	0.4385	0.2545
BT-20	Barasertib	1.11	uM	LJP5	2	D09	72	hr	1097	1799	3877	0.4639	0.3119
BT-20	Barasertib	1.11	uM	LJP5	3	D09	72	hr	1097	1950	3925	0.4968	0.3671

|<
<<
Previous
Page 300 of 535
Next
>>
>
7476 to 7500 of 13356 records
per page:

HMS LINCS Project

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 10 of 15: Cell count and normalized growth rate inhibition values within biological replicate 3. - Dataset (ID:20247)